Starling Oncology Institute(STLN)
$3.40-0.14 (-3.95%)
STLN
Starling Oncology Institute earnings date
$3.40
At close:-0.14 (-3.95%)
Want to see STLN full AI Analyst Report?
Starling Oncology Institute (STLN) Q2 2023 Earnings Report
213 Followers
STLN Q2 2023 EPS Results
- Actual EPS
- -$0.19
- Consensus EPS
- -$0.17
- Beat/Miss
- Missed by -$0.02
- One Year Ago EPS
- -$0.09
STLN Q2 2023 Revenue Results
- Actual Revenue
- $80.22M
- Expected Revenue
- $73.80M
- Beat/Miss
- Beat by +$6.42M
- YoY Revenue Growth
- +31.69%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
STLN Upcoming Earnings
Starling Oncology Institute's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
STLN Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
STLN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -0.04- | -0.06 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.05-0.13 | -0.14 | 7.14% (+0.01) | |
| Aug 06, 2026 | 2026 (Q2) | -0.06-0.08 | -0.15 | 46.67% (+0.07) | |
| May 07, 2026 | 2026 (Q1) | -0.09-0.02 | -0.21 | 90.48% (+0.19) | |
| Mar 12, 2026 | 2025 (Q4) | -0.09-0.06 | -0.14 | 57.14% (+0.08) | |
| Nov 13, 2025 | 2025 (Q3) | -0.11-0.14 | -0.18 | 22.22% (+0.04) | |
| Aug 13, 2025 | 2025 (Q2) | -0.12-0.15 | -0.17 | 11.76% (+0.02) | |
| May 14, 2025 | 2025 (Q1) | ―-0.21 | -0.22 | 4.55% (+0.01) | |
| Mar 24, 2025 | 2024 (Q4) | ―-0.14 | -0.21 | 33.33% (+0.07) | |
| Nov 13, 2024 | 2024 (Q3) | ―-0.18 | -0.19 | 5.26% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

